PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact


Search


PDF Archive search engine
Last database update: 07 July at 06:19 - Around 220000 files indexed.

Show results per page

Results for «tumor»:


Total: 500 results - 0.059 seconds

Tumor-Cells 100%

CREARIVE BIOARRAY Creative · Bioarray A Division of Creative Dynamics Inc Tumor Cells are those cells divide relentlessly It is a abnormal process make the healthy cells stop dividing A Division of Creative Dynamics Inc Pruducts Creative Bioarray maintains various CONT ENT Human and Animal TUMOR CELLS tumor cell lines that are invaluable for medical, scientific and pharmaceutical institutions.

https://www.pdf-archive.com/2018/11/23/tumor-cells/

23/11/2018 www.pdf-archive.com

Munson 75 97%

Animals treated for 10 consecutive days with as-WC, beginning the day after tumor implantation, demonstrated a dose-dependent action of retarded tumor growth.

https://www.pdf-archive.com/2016/01/22/munson-75/

22/01/2016 www.pdf-archive.com

ADCs for Clinical Research in the Global Market 97%

HER2/neu ph2 ADC Therapeutics CD19 ph2 relapsed or refractory DLBCL ADC Therapeutics CD25 ph2 Hodgkin lymphoma AbbVie c-met ph2 NSCLC 6SK BCMA ph2 Multiple myeloma Roche LIV1 Ph1/2 Triple Negative Breast Cancer(TNBC) Daiichi Sankyo HER3 Ph1/2 BMS-986148 BMS mesothelin Ph1/2 solid tumor enapotamab Seattle Genetics AXL Ph1/2 solid tumor mirvetuximab soravtansine trastuzumab duocarmazine trastuzumab Bio-Thera maytansine Solutions anetumab ravtansine tisotumab vedotin Remegen RC48 loncsstuximab tesirine camidanlumab tesirine telisotuzumab vedotin belantamab mafodotin ladiratuzumab vedotin patritumab deruxtecan HER2 positive metastatic breast cancer HER2 positive metastatic breast cancer pancreatic cancer ovarian cancer HER2 positive metastatic breast cancer HER3 positive metastatic breast cancer https://www.biochempeg.com Biochempeg Scientific Inc.

https://www.pdf-archive.com/2020/02/28/adcs-for-clinical-research-in-the-global-market/

28/02/2020 www.pdf-archive.com

Most commons by Yatin Talwar 96%

Most common primary malignant orbital tumor in childhood :

https://www.pdf-archive.com/2014/05/17/most-commons-by-yatin-talwar/

17/05/2014 www.pdf-archive.com

JDIT-2014-1030-006 96%

Some neuroendocrine tumor cells express hormone receptors with a strong avidity for specific hormones that can be exploited for diagnosis and treatment purposes.

https://www.pdf-archive.com/2017/05/30/jdit-2014-1030-006/

30/05/2017 www.pdf-archive.com

IJEAS0404028 95%

2394-3661, Volume-4, Issue-4, April 2017 An Efficient Detection Of Brain Tumor In MR Brain Images Using Particle Swarm Optimization Somya Yadav, Dr.

https://www.pdf-archive.com/2017/09/10/ijeas0404028/

10/09/2017 www.pdf-archive.com

IJETR2101 95%

2321-0869 (O) 2454-4698 (P), Volume-7, Issue-2, February 2017 Brain Tumor Detection using GLCM with the help of KSVM Megha Kadam, Prof.Avinash Dhole  of large number of MRI slices (Normal or Abnormal) may leads to miss-classification, that can classify the type of brain tumor.

https://www.pdf-archive.com/2017/12/24/ijetr2101/

24/12/2017 www.pdf-archive.com

2017DBS Antibody Flyer 102017 web 94%

Mesothelin NKX3.1 Mesothelin is a valuable marker for pancreatic ductal adenocarcinoma due to its strong reactivity in tumor tissue and absence in normal pancreas.

https://www.pdf-archive.com/2017/10/30/2017dbs-antibody-flyer-102017-web/

30/10/2017 www.pdf-archive.com

Anorectal-Applicator 93%

Unique Device Dimensions »» 2.3 cm uninflated insertion diameter for ease of placement »» 8-10cm effective treatment zone allows treatment of entire rectum without repositioning Visible Dual Balloon Construction »» 3.5-4cm inner balloon inflated diameter creates consistent, repeatable source catheter positioning »» Outer balloon creates protective spacing between source catheters and tissue, fully distending the rectum ensuring repeatable tumor coverage Repeatable »» Radio-opaque contrast markers visible under X-ray, CT and MRI ensure consistent device placement »» Contrast Markers and handle markings ensure depth and rotational consistency »» Inner balloon design ensures precise, consistent source catheter positioning Optimal »» Consistent fill volumes ensure repeatable tissue spacing »» Compliant outer balloon ensures optimal tissue separation and conformity around tumors »» Non-compliant inner balloon supports 8 evenly spaced treatment catheters ensuring optimal positioning for surface dose control »» Device construction and materials designed to take full advantage of MRI guided brachytherapy Distributed by 490 West 84th St Hialeah, FL 33014 (844) ANCERMED • (844) 262-3763 New Horizons in Radiation Oncology www.ancermedical.com Made in USA Patents Pending MKT-0001-00- Rev 3 “The uniquely compliant design of the AR Applicator allows exophytic tumors to press closer to the source catheters than healthy tissue, resulting in the ability to deliver a very high dose to the tumor, maintaining superior dose coverage of the target volume while sparing healthy tissue.

https://www.pdf-archive.com/2016/07/12/anorectal-applicator/

12/07/2016 www.pdf-archive.com

Abstract 93%

These findings were confirmed in vivo by implanting mouse xenografts of HCC827 cells with suppressed HUWE1 expression and monitoring tumor development in response to erlotinib.

https://www.pdf-archive.com/2017/06/13/abstract/

13/06/2017 www.pdf-archive.com

ER0884 93%

Liliana Fonseca (Endocrinologia, CHP-HSA) Tumor neuroendócrino gástrico - o novo dilema Experiência do Hospital Beatriz Ângelo (HBA) Apresentação:

https://www.pdf-archive.com/2018/01/16/er0884/

16/01/2018 www.pdf-archive.com

cv-pantel 93%

Institute of Tumor Biology, University Hospital Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany Phone:

https://www.pdf-archive.com/2018/03/19/cv-pantel/

19/03/2018 www.pdf-archive.com

Brain Tumor Survival Rate Study - Google Forms 93%

1/7/2016 Brain Tumor Survival Rate Study ­ Google Forms gujunilesh@gmail.com Edit this form 6 responses View all responses  Publish analytics Summary Your Information Your role 16.7% 16.7% 16.7% 16.7% 33.3% Patient 2 33.3% Caregiver ­ Parent 1 16.7% Caregiver ­ Spouse 1 16.7% Caregiver ­ Child 1 16.7% Caregiver ­ Extended Family 0 0% Caregiver ­ Friends 0 0% Medical (Doctor, Nurse, etc) 0 0% Other 1 16.7% Patient's Information Gender Male 3 50% Female 3 50% https://docs.google.com/forms/d/1ykR59zD2sg3hVlMVOXSn86HHYcqxWOSUdhcKNfRxvnA/viewanalytics#start=publishanalytics 1/15 1/7/2016 Brain Tumor Survival Rate Study ­ Google Forms 50% Date of Birth Jul 1942 10 Jun 1956 6 Aug 1956 24 Nov 1964 30 Sep 1972 10 Jun 1981 21 50% Age when Initially Diagnosed 34 42 50 57 59 73 Patient's Location South Africa St Louis, MO Benton Ky. USA Czech Philadelphia, PA, USA Chicago, IL Race https://docs.google.com/forms/d/1ykR59zD2sg3hVlMVOXSn86HHYcqxWOSUdhcKNfRxvnA/viewanalytics#start=publishanalytics 2/15 1/7/2016 Brain Tumor Survival Rate Study ­ Google Forms White Black Hispanic Middle Eastern Asian South Asian (… White 5 83.3% Black 0 0% Hispanic 0 0% Middle Eastern 0 0% Asian 0 0% South Asian (Indian) 1 16.7% Other 0 0% Other 0 1 2 3 4 What led to the initial diagnosis?

https://www.pdf-archive.com/2016/01/08/brain-tumor-survival-rate-study-google-forms/

08/01/2016 www.pdf-archive.com

Bone Cancer treatment 93%

Bone Cancer Treatment Keyword bone cancer treatment,bone cancer,bone cancer symptoms,bone cancer prognosis,osteosarcoma,signs of bone cancer,types of bone cancer,bone marrow cancer,bone cancer pain ,cancer of the bone,bone cancer stages,bone cancer survival rate,is bone cancer curable,what causes bone cancer,stage 4 bone cancer,bone marrow cancer symptoms,bone cancer causes,can bone cancer be cured,what is bone cancer,bone tumor,secondary bone cancer,metastatic bone cancer,bone pain,hip pain cancer,secondary bone cancer prognosis,bone tumor symptoms,bone cancer diagnosis,bone cancer survival,bone cancer in children,bone cancer symptoms in leg,is bone cancer painful,bone lesions,how is bone cancer treated,symptoms of bone cancer in hip,leg cancer symptoms,back bone cancer,bone cancer signs and symptoms,primary bone cancer,leg cancer,knee cancer symptoms,bone cancer in leg,knee cancer,bone cancer life expectancy,cancer treatment,best cancer hospitals,best cancer treatment,best bone cancer hospital,best cancer treatment centers in the world,cancer treatment centers of america Snippet:

https://www.pdf-archive.com/2018/12/25/bone-cancer-treatment/

25/12/2018 www.pdf-archive.com

2534 - MD Anderson Cancer Center Madrid- Pathology Meeting - program 92%

Barcelona, Spain 09:30 - 10:15 Tumor microenvironment and pancreatic cancer progression Dr.

https://www.pdf-archive.com/2018/06/18/untitled-pdf-document/

18/06/2018 www.pdf-archive.com

mammograms 92%

The smaller the tumor is when it’s identified, the better the woman’s odds of survival. This makes breast cancer screening — looking for tumors in women who otherwise have no symptoms — a central component of prevention.

https://www.pdf-archive.com/2017/02/23/mammograms-1/

23/02/2017 www.pdf-archive.com

JDIT-2014-1007-004 91%

It is known that the estrogen receptor (ER) status of a tumor is an important prognostic and predictive indicator in breast cancer.

https://www.pdf-archive.com/2017/05/30/jdit-2014-1007-004/

30/05/2017 www.pdf-archive.com

Weinstein & Ciszek 2002 91%

evolutionary origins and modern implications of the trade-off between tumor-suppression and tissue-repair Bret S.

https://www.pdf-archive.com/2017/06/11/weinstein-ciszek-2002/

11/06/2017 www.pdf-archive.com

sample 81 82 83 91%

Bronchial hamartoma-benign tumor composed of lung tissue and cartilage;

https://www.pdf-archive.com/2017/12/14/sample-81-82-83/

14/12/2017 www.pdf-archive.com

Boston Biomarker Poster 03192014 91%

A MULTIANALYTE ALGORITHM PCR-BASED BLOOD TEST OUTPERFORMS SINGLE ANALYTE ELISA-BASED BLOOD TESTS FOR NEUROENDOCRINE TUMOR DETECTION A key issue in management of neuroendocrine tumors (NETs) is specific and sensitive biomarkers.

https://www.pdf-archive.com/2014/03/21/boston-biomarker-poster-03192014/

21/03/2014 www.pdf-archive.com

JDIT-2016-0712-022 91%

published online 12 July 2016) Abstract Differentiated thyroid cancer (DTC) is a common endocrine tumor with increasing incidence and excellent prognosis.

https://www.pdf-archive.com/2017/05/30/jdit-2016-0712-022/

30/05/2017 www.pdf-archive.com

cyberknife treatment for cancers1092 90%

Cyberknife system makes use of image guidance in order to track and continues to adjust treatments for the patients and the movement of tumor.

https://www.pdf-archive.com/2013/11/05/cyberknife-treatment-for-cancers1092/

05/11/2013 www.pdf-archive.com

kidney pain 90%

Urinary tract disorder Nausea and Vomiting Severe Fever Blood in urine or abnormal urine color Swelling of hands and legs Pain mainly in the groin region Indication of a Kidney Tumor Kidney tumor symptoms are not clearly noticeable in the early stages of kidney tumor.

https://www.pdf-archive.com/2013/06/12/kidney-pain/

12/06/2013 www.pdf-archive.com

An Overview of Basal Cell Carcinoma 90%

2011) and more than one subtype may be present in a single tumor (Ro et al.

https://www.pdf-archive.com/2013/02/24/an-overview-of-basal-cell-carcinoma/

24/02/2013 www.pdf-archive.com